Andrew R Miksztal
Inventor
Stats
- 2 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 17 US Applications Filed
- 84 Total Citation Count
- Aug 17, 2023 Most Recent Filing
- Dec 5, 1994 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
HOFFMANN-LA ROCHE INC. | 1
1 | 1994
1995 |
SYNTEX (U.S.A.) INC. | 1
1 | 1994
1995 |
DURECT CORPORATION | 1
| 2004
|
Inventor Addresses
Address | Duration |
---|---|
Menlo Park, CA | Aug 06, 96 - Aug 13, 96 |
PALo ALTO, CA, US | Dec 26, 24 - Dec 26, 24 |
Palo Alto, CA | Jun 17, 04 - Jun 17, 04 |
Palo Alto, CA, US | Sep 05, 19 - Feb 18, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
A61J: | CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 15 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12226423 | 2025 | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide | 0 |
2024/0425,545 | 2024 | 25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, Same | 0 |
2024/0115,463 | 2024 | SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED METHODS | 0 |
2023/0365,618 | 2023 | CRYSTALLINE THIOCHOLESTEROL | 0 |
11771624 | 2023 | Sustained release drug delivery systems with reduced impurities and related methods | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.